Proscia report reveals initial deployment of legacy systems has paved the way for imminent shift to modern software needed to accelerate AI-powered drug R&D PHILADELPHIA – June 13, 2023 –  Nearly three-fourths of life sciences...

In this free webinar from Xtalks, learn how digital pathology advances preclinical R&D and improves the quality and efficiency of pathology workflows. Attendees will discover the current status of histopathology R&D and explore key...

Pathology in life sciences research and development (R&D) can be heavy on collaboration. That’s a good thing – because science is a team effort. But as you engage more stakeholders, lab professionals, outside partners, and compliance...

The Institute of Human Biology aims to better predict which drug candidates are safe and most effective in patients by evolving and increasing the use of human model systems. Human model systems are miniature living 'replicas' of...

Xtalks: Featured speaker from Proscia will share real-world examples and use cases during free event. TORONTO, ONTARIO, CANADA (PRWEB) MAY 01, 2023 Preclinical research and development (R&D) centers around workflows that generate more...

Altasciences and Proscia: Driving more complete decisions for biopharmaceutical companies with modern digital pathology LAVAL, QUÉBEC and PHILADELPHIA – March 21, 2023 – Proscia®, a leading provider of digital and computational...